Magnesium sulfate versus combination of magnesium and phentolamine for control of blood pressure in pregnancy induced hypertension

Magnesium sulfate versus combination of magnesium and phentolamine for control of blood pressure in pregnancy induced hypertension - Magnesium sulfate versus combination of magnesium and phentolamine in pregnancy induced hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039038

Enrollment

Registered

2020-08-01

Start date

2020-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood pressure control in preclampsia

Interventions

control group C. will be given an intravenous infusion of 25 ml of magnesium sulfate and 100 ml of glucose solution with a concentration of 5% the infusion will be finished in 30 min. The patients wil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who will be included conformed to the diagnostic criteria of moderate and severe gestational hypertension.

Exclusion criteria

Exclusion criteria: intolerance or allergy to magnesium sulfate or phentolamine; mental illnesses and serious medical diseases as cerebral compromised or renal insufficiency

Design outcomes

Primary

Measure	Time frame
Efficacy of the combination of magnesium sulfate and phentolamine in the treatment of patients with hypertensive disorder with pregnancy (HDCP)	—

Countries

Africa

Contacts

Public ContactGhada Hassan

Menofia University Anesthesia department

ghada.ibrahim@med.menofia.edu.eg00201001592001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026